secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001193125-22-142304
Event type: leadership
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q1 revenue $50.1M (+36% YoY); CEO transition to Musslewhite in August
--------------------------------------------------------------------------------

- Revenue $50.1M, +36% YoY; net loss ($13.1M) widened from ($10.5M); adjusted net income $7.7M (vs $2.6M).
- Adjusted EBITDA $14.0M (28% of revenue) vs $14.1M (38%) in Q1 2021; cash from ops $13.6M.
- Q2 2022 guidance: revenue $53-54M (+34%); full year revenue $220.5-224.5M (+33-35%).
- Robert Musslewhite (President) appointed CEO effective Aug 1, 2022; founder Jason Krantz becomes Executive Chairman.
- Musslewhite receives annual base salary $429k, RSU grants, and change-in-control benefits; Krantz retains reduced salary and equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/0001193125-22-142304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312522142304/d329213d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-142304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer